Published in Antimicrob Agents Chemother on December 23, 2013
A Telomeric Cluster of Antimony Resistance Genes on Chromosome 34 of Leishmania infantum. Antimicrob Agents Chemother (2016) 0.77
Biophysical and Pharmacological Characterization of Energy-Dependent Efflux of Sb in Laboratory-Selected Resistant Strains of Leishmania (Viannia) Subgenus. Front Cell Dev Biol (2017) 0.75
Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene (1985) 213.67
Leishmaniasis worldwide and global estimates of its incidence. PLoS One (2012) 18.07
Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol (2007) 7.36
Drug resistance in leishmaniasis. Clin Microbiol Rev (2006) 7.35
Life without transcriptional control? From fly to man and back again. EMBO J (2002) 4.14
Stable transfection of the human parasite Leishmania major delineates a 30-kilobase region sufficient for extrachromosomal replication and expression. Mol Cell Biol (1990) 4.13
Drug resistance in Indian visceral leishmaniasis. Trop Med Int Health (2001) 3.08
Macrophage colony-stimulating factor (rM-CSF) stimulates pinocytosis in bone marrow-derived macrophages. J Exp Med (1989) 2.74
Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004. Lancet Infect Dis (2005) 2.06
Transfection of Leishmania enriettii and expression of chloramphenicol acetyltransferase gene. Proc Natl Acad Sci U S A (1989) 1.88
Drug uptake and modulation of drug resistance in Leishmania by an aquaglyceroporin. J Biol Chem (2004) 1.79
Novel Intracellular SbV reducing activity correlates with antimony susceptibility in Leishmania donovani. J Biol Chem (2000) 1.54
Leishmania major: promastigotes induce expression of a subset of chemokine genes in murine macrophages. Exp Parasitol (1997) 1.51
Molecular mechanisms of antimony resistance in Leishmania. J Med Microbiol (2007) 1.50
Co-amplification of the gamma-glutamylcysteine synthetase gene gsh1 and of the ABC transporter gene pgpA in arsenite-resistant Leishmania tarentolae. EMBO J (1997) 1.49
Elevated levels of polyamines and trypanothione resulting from overexpression of the ornithine decarboxylase gene in arsenite-resistant Leishmania. Mol Microbiol (1999) 1.40
A proteomics screen implicates HSP83 and a small kinetoplastid calpain-related protein in drug resistance in Leishmania donovani clinical field isolates by modulating drug-induced programmed cell death. Mol Cell Proteomics (2006) 1.36
Gene expression analysis of the mechanism of natural Sb(V) resistance in Leishmania donovani isolates from Nepal. Antimicrob Agents Chemother (2005) 1.34
Antimony uptake systems in the protozoan parasite Leishmania and accumulation differences in antimony-resistant parasites. Antimicrob Agents Chemother (2003) 1.29
Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes. Antimicrob Agents Chemother (1999) 1.25
Functional genetic identification of PRP1, an ABC transporter superfamily member conferring pentamidine resistance in Leishmania major. Mol Biochem Parasitol (2003) 1.17
Resistance to treatment in Kala-azar: speciation of isolates from northeast India. Am J Trop Med Hyg (2001) 1.17
Leishmania major Hsp100 is required chiefly in the mammalian stage of the parasite. Mol Cell Biol (1997) 1.16
Inhibition of ABC transporters abolishes antimony resistance in Leishmania Infection. Antimicrob Agents Chemother (2007) 1.15
Molecular mechanisms of drug resistance in natural Leishmania populations vary with genetic background. PLoS Negl Trop Dis (2012) 1.11
Treatment of visceral leishmaniasis. Expert Opin Pharmacother (2005) 1.11
Leishmania donovani heat shock protein 100. Characterization and function in amastigote stage differentiation. J Biol Chem (1998) 1.10
Antimony-resistant but not antimony-sensitive Leishmania donovani up-regulates host IL-10 to overexpress multidrug-resistant protein 1. Proc Natl Acad Sci U S A (2013) 1.07
Functional identification of galactosyltransferases (SCGs) required for species-specific modifications of the lipophosphoglycan adhesin controlling Leishmania major-sand fly interactions. J Biol Chem (2003) 1.04
Antimonial resistance in Leishmania donovani is associated with increased in vivo parasite burden. PLoS One (2011) 1.03
Identification of a Leishmania infantum gene mediating resistance to miltefosine and SbIII. Int J Parasitol (2008) 1.02
Leishmania LPG3 encodes a GRP94 homolog required for phosphoglycan synthesis implicated in parasite virulence but not viability. EMBO J (2002) 1.00
Virulence of Leishmania infantum is expressed as a clonal and dominant phenotype in experimental infections. Infect Immun (2001) 0.97
Management of visceral leishmaniasis: Indian perspective. J Postgrad Med (2005) 0.96
The heat shock protein HSP70 and heat shock cognate protein HSC70 contribute to antimony tolerance in the protozoan parasite leishmania. Cell Stress Chaperones (2004) 0.91
Amplification of ABC transporter gene pgpA and of other heavy metal resistance genes in Leishmania tarentolae and their study by gene transfection and gene disruption. Methods Enzymol (1998) 0.89
A novel marker, ARM58, confers antimony resistance to Leishmania spp. Int J Parasitol Drugs Drug Resist (2013) 0.84
Functional cloning as a means to identify Leishmania genes involved in drug resistance. Mini Rev Med Chem (2006) 0.79
The Hsp90-Sti1 interaction is critical for Leishmania donovani proliferation in both life cycle stages. Cell Microbiol (2012) 0.79
Overexpression of a single Leishmania major gene enhances parasite infectivity in vivo and in vitro. Mol Microbiol (2010) 0.77
Indian kala-azar--better tools needed for diagnosis and treatment. J Postgrad Med (2003) 0.76
An exosome-based secretion pathway is responsible for protein export from Leishmania and communication with macrophages. J Cell Sci (2010) 1.67
Comparison of the A2 gene locus in Leishmania donovani and Leishmania major and its control over cutaneous infection. J Biol Chem (2003) 1.42
Leishmania exosomes modulate innate and adaptive immune responses through effects on monocytes and dendritic cells. J Immunol (2010) 1.32
Tryparedoxin peroxidase of Leishmania donovani: molecular cloning, heterologous expression, specificity, and catalytic mechanism. Arch Biochem Biophys (2002) 1.11
Phosphoproteome dynamics reveal heat-shock protein complexes specific to the Leishmania donovani infectious stage. Proc Natl Acad Sci U S A (2010) 1.08
Leishmania infantum expresses a mitochondrial nuclease homologous to EndoG that migrates to the nucleus in response to an apoptotic stimulus. Mol Biochem Parasitol (2008) 1.03
Identification of a Leishmania infantum gene mediating resistance to miltefosine and SbIII. Int J Parasitol (2008) 1.02
Inhibition of HSP90 in Trypanosoma cruzi induces a stress response but no stage differentiation. Eukaryot Cell (2002) 0.96
Secreted virulence factors and immune evasion in visceral leishmaniasis. J Leukoc Biol (2012) 0.94
Developmentally induced changes of the proteome in the protozoan parasite Leishmania donovani. Proteomics (2003) 0.93
Structural characterization of beta-sheeted oligomers formed on the pathway of oxidative prion protein aggregation in vitro. J Struct Biol (2006) 0.92
Characterization of a subunit of the outer dynein arm docking complex necessary for correct flagellar assembly in Leishmania donovani. PLoS Negl Trop Dis (2010) 0.87
A Leishmania donovani gene that confers accelerated recovery from stationary phase growth arrest. Int J Parasitol (2004) 0.85
Leishmania major: identification of developmentally regulated proteins in procyclic and metacyclic promastigotes. Exp Parasitol (2008) 0.84
Rapid identification of Leishmania spp. in formalin-fixed, paraffin-embedded tissue samples by fluorescence in situ hybridization. Trop Med Int Health (2012) 0.83
The co-chaperone SGT of Leishmania donovani is essential for the parasite's viability. Cell Stress Chaperones (2009) 0.82
Complement C3 is required for the progression of cutaneous lesions and neutrophil attraction in Leishmania major infection. Med Microbiol Immunol (2004) 0.82
Spontaneous recovery of pathogenicity by Leishmania major hsp100-/- alters the immune response in mice. Infect Immun (2006) 0.82
One-step generation of double-allele gene replacement mutants in Leishmania donovani. Int J Parasitol (2008) 0.81
LmxMPK4, an essential mitogen-activated protein kinase of Leishmania mexicana is phosphorylated and activated by the STE7-like protein kinase LmxMKK5. Int J Parasitol (2010) 0.80
Comparative analysis of the human and chicken prion protein copper binding regions at pH 6.5. J Biol Chem (2005) 0.79
The Hsp90-Sti1 interaction is critical for Leishmania donovani proliferation in both life cycle stages. Cell Microbiol (2012) 0.79
Leishmania donovani HslV does not interact stably with HslU proteins. Int J Parasitol (2012) 0.79
The loss of virulence of histone H1 overexpressing Leishmania donovani parasites is directly associated with a reduction of HSP83 rate of translation. Mol Microbiol (2013) 0.78
Oligomerization of the proteolytic products is an intrinsic property of prion proteins. Biochem Biophys Res Commun (2004) 0.78
The Leishmania donovani chaperone cyclophilin 40 is essential for intracellular infection independent of its stage-specific phosphorylation status. Mol Microbiol (2014) 0.78
Stage-specific expression of the mitochondrial co-chaperonin of Leishmania donovani, CPN10. Kinetoplastid Biol Dis (2005) 0.77
Overexpression of a single Leishmania major gene enhances parasite infectivity in vivo and in vitro. Mol Microbiol (2010) 0.77
Leishmania donovani P23 protects parasites against HSP90 inhibitor-mediated growth arrest. Cell Stress Chaperones (2015) 0.75
Synthetic human prion protein octapeptide repeat binds to the proteinase K active site. Biochem Biophys Res Commun (2004) 0.75